* K: Session in Korean
| Time | ROOM 1 (300B) |
ROOM 2 (203+204) |
ROOM 3 (205+206) |
ROOM 4 (202) |
ROOM 5 (201) |
Time |
|---|
* K: Session in Korean
| Time | ROOM 6 (103+104) |
ROOM 7 (105+106) |
ROOM 8 (102) |
ROOM 9 (101) |
Exhibition Hall (300A+C) |
Time |
|---|
| 07:30-08:50 |  KASL SIG 5. The Korean Study Group of Portal Hypertension07:30-08:50 |
KASL SIG 6. The Korean Alcohol-Related Problem Study Group 07:30-08:50 |
Industry Forum 2 08:00-08:50 |
07:30-08:50 | ||
|---|---|---|---|---|---|---|
| 09:10-10:30 | Data Science Camp 2AI in Hepatology 09:10-10:30 |
Poster Oral Presentation 09:30-10:30 |
09:10-10:30 | |||
| 10:30-10:50 | Coffee Break 10:30-10:50 |
Booth & Poster Exhibition 08:00-16:10 |
10:30-10:50 | |||
| 10:50-11:20 | 10:50-11:20 | |||||
| 11:20-12:20 | 11:20-12:20 | |||||
| 12:20-13:10 | Luncheon Symposium 10 12:20-13:10 |
Luncheon Symposium 11 12:20-13:10 |
12:20-13:10 | |||
| 13:10-14:30 | KASL Symposium 4Alcohol-Associated Liver Disease 13:10-14:30 |
Free Paper 11 13:10-14:30 |
Free Paper 12 13:10-14:30 |
Free Paper 13 13:10-14:30 |
13:10-14:30 | |
| 14:30-14:50 | Coffee Break 14:30-14:50 |
14:30-14:50 | ||||
| 14:50-15:50 | 14:50-15:50 | |||||
| 15:50-16:10 | 15:50-16:10 | |||||
07:30-08:50
KASL Special Interest Group 4. The Korean Viral Hepatitis Study Group
Advancing Insights into HBV Pathogenesis and Therapy
Chair: Hyung Joon Yim (Korea Univ.), Takehisa Watanabe (Kumamoto Univ., Japan)
- 07:30-08:00
-
Maternal Chronic HBV Infection and Its Potential Impact on Fetal Development and Congenital Anomalies
Yewan Park (Kyung Hee Univ.)
- 08:00-08:25
-
A Novel Anti-HBV Compound Reduces HBsAg and HBV-DNA by Destabilizing HBV-RNA
Takehisa Watanabe (Kumamoto Univ., Japan)
- 08:25-08:50
-
TERT Alterations and HBV Integration in Young-Age HBV-Related HCC
Jin Seoub Kim (The Catholic Univ. of Korea)
09:10-10:30
KASL-AASLD Joint Symposium 2
Looking into the Future of Hepatology
Chair: Silvia C. Sookoian (Maimonides Univ., Argentina), Sook-Hyang Jeong (Seoul National Univ.)
- 09:10-09:30
-
Anti-Fibrotic and Anti-Cirrhotic Approaches in Chronic Liver Disease
Seung Up Kim (Yonsei Univ.)
- 09:30-09:50
-
Future Directions in Liver Transplant Allocation Policies: Beyond MELD
W. Ray Kim (Mayo Clinic, USA)
- 09:50-10:10
-
Gut Microbiome-Targeted Therapies to Enhance Treatment Outcomes of Liver Diseases
Ki Tae Suk (Hallym Univ.)
- 10:10-10:30
-
Molecular and Immunological Biomarkers for Hepatocellular Carcinoma to Guide Personalized Treatment Decisions
Renumathy Dhanasekaran (Stanford Univ., USA)
10:50-11:20
President's Choice Lecture
Chair: Yoon Jun Kim (Seoul National Univ.)
- 10:50-11:20
-
Management of Portal Hypertension in Advanced Cirrhosis
Shiv Kumar Sarin (Institute of Liver and Biliary Sciences, India)
11:20-12:20
Plenary Presentation 2
Chair: June Sung Lee (Inje Univ.), Si Hyun Bae (The Catholic Univ. of Korea), Kwang-Woong Lee (Seoul National Univ.)
13:10-14:30
KASL Symposium 3
Emerging Concepts, Challenges, and Therapeutic Frontiers of Metabolic Dysfunction–Associated Steatotic Liver Disease
Chair: Tatsuya Kanto (National Center for Global Health and Medicine, Japan), Won Kim (Seoul National Univ.)
- 13:10-13:30
-
Identification of Genes Conferring Individual-Level Variation Responsible for MASLD Using Single-Cell eQTL Analysis
Murim Choi (Seoul National Univ.)
- 13:30-13:50
-
GLP-1 Receptor Agonists in MASLD: Current Clinical Status and Future Directions
Sang Bong Ahn (Eulji Univ.)
- 13:50-14:10
-
Resmetirom's Promise and the Challenges Ahead
To Be Decided
- 14:10-14:30
-
New Drug Discovery Based on Multi-Omics
Silvia C. Sookoian (Maimonides Univ., Argentina)
14:50-15:50
The Liver Week 2025 Debrief
Chair: Ju Hyun Shim (KASL), Su Jong Yu (KLCA), Hae Won Lee (KLTS)
- 14:50-15:05
-
KASL
Eun Sun Jang (Seoul National Univ.)
- 15:05-15:20
-
KLCA
Yuri Cho (National Cancer Center)
- 15:20-15:35
-
KAHBPS
Min-Su Park (Kyung Hee Univ.)
- 15:35-15:50
-
KLTS
Suk Kyun Hong (Seoul National Univ.)
07:30-08:50
KLCA Symposium 3
Revisiting and Expanding Hepatocellular Carcinoma Treatment Paradigms: From Standard to Innovative Therapies
Chair: Jong Young Choi (Chung-Ang Univ.), Augusto Villanueva (Icahn School of Medicine at Mount Sinai, USA)
- 07:30-07:50
-
Systemic Therapy and Transarterial Chemoembolization in BCLC Intermediate Stage: A Survival Boost?
Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)
- 07:50-08:10
-
TACE/TARE in Advanced HCC: Can They Coexist with Systemic Therapy?
Hyo-Cheol Kim (Seoul National Univ.)
- 08:10-08:30
-
The Emerging Role of Immuno-Oncology Therapy in Neo- and Adjuvant Treatment for HCC
Jacob George (The Univ. of Sydney, Australia)
- 08:30-08:50
-
Cancer Vaccines in HCC: Current Status and Future Directions
Jeong Heo (Pusan National Univ.)
09:10-10:30
KLCA-TLCA Joint Symposium
Innovating and Expanding Surgical Horizons for Hepatocellular Carcinoma in the Immunotherapy Era
Chair: Kyung Sik Kim (Yonsei Univ.), Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)
- 09:10-09:30
-
Surgical Innovations for Advanced HCC in the Immunotherapy Era: Korean Expertise
Gi Hong Choi (Yonsei Univ.)
- 09:30-09:50
-
Advancing Liver Surgery in the Immunotherapy Era: The Taiwanese Experience
Ming-Chin Yu (Chang Gung Univ., Taiwan)
- 09:50-10:10
-
Combining Immunotherapy with Local Treatments: New Directions for HCC Management in Korea
Yun Bin Lee (Seoul National Univ.)
- 10:10-10:30
-
Immune Checkpoint Inhibitors and Biomarker Discovery: Tailoring Treatment for HCC
Chien-Hung Chen (National Taiwan Univ., Taiwan)
07:30-08:50
KLTS Symposium 1
Living Donor Liver Transplantation-Based Protocol for Hepatocellular Carcinoma: Intention-to-Treat Approach with Pre-Transplant Therapy
Chair: Myoung Soo Kim (Yonsei Univ.), Il Han Song (Dankook Univ.)
- 07:30-07:50
-
Definition and Current Status of Bridging, Neoadjuvant, Downstaging, and Conversion Therapies
Moon Haeng Hur (Seoul National Univ.)
- 07:50-08:10
-
Pros and Cons of Repetitive Transarterial Chemoembolization or Other Locoregional Therapies Prior to Liver Transplantation
Dong Ho Hyun (Sungkyunkwan Univ.)
- 08:10-08:30
-
Practical Factors Considered in Immunotherapy Prior to Liver Transplantation
Dong Hyun Sinn (Sungkyunkwan Univ.)
- 08:30-08:50
-
Lessons for Developing Protocols Based on Real-World Data
Dong-Hwan Jung (Univ. of Ulsan)
09:10-10:30
KLTS Symposium 2
Technical Hurdles in Living Donor Liver Transplantation
Chair: Dong-Sik Kim (Korea Univ.), Munkhbat Radnaabazar (National Cancer Center, Mongolia)
- 09:10-09:30
-
Outflow Reconstruction Tips in Liver Transplant for Budd-Chiari Syndrome
Gyu-seong Choi (Sungkyunkwan Univ.)
- 09:30-09:50
-
Portal Vein Reconstruction in a Recipient with Atretic Portal Vein
Kwang-Woong Lee (Seoul National Univ.)
- 09:50-10:10
-
Difficult Arterial Reconstruction: Multiple Arteries or Size-Mismatched Situations
Chul Soo Ahn (Univ. of Ulsan)
- 10:10-10:30
-
Various Bile Duct Anastomosis Methods for Multiple Duct Situations
Tae-Seok Kim (Keimyung Univ.)
13:10-14:30
KLTS Symposium 3
Frontline Approaches in Deceased Donor Liver Transplantation: Optimizing Outcomes with Limited Liver Grafts
Chair: Yang Won Nah (Univ. of Ulsan), Young Kyoung You (The Catholic Univ. of Korea)
- 13:10-13:30
-
Current Status and Challenges of the Liver Allocation System for Deceased Donors in Korea
Young-In Yoon (Univ. of Ulsan)
- 13:30-13:50
-
Patient Selection and Timing of Referral for Liver Transplantation in Acute Alcoholic Hepatitis
Do Seon Song (The Catholic Univ. of Korea)
- 13:50-14:10
-
Perioperative Challenges and Solutions for Patients with Chronic Liver Disease Undergoing Deceased Donor Liver Transplantation
Young Chul Yoon (The Catholic Univ. of Korea)
- 14:10-14:30
-
Predicting Futile Outcomes in Deceased Donor Liver Transplantation: Focus on Acute-on-Chronic Liver Failure
YoungRok Choi (Seoul National Univ.)
07:30-08:50
KASL SIG 5. The Korean Study Group of Portal Hypertension
09:10-10:30
Data Science Camp 2
Artificial Intelligence in Hepatology
Chair: Jin-Woo Lee (Inha Univ.), Kang Mo Kim (Univ. of Ulsan)
- 09:10-09:35
-
Hepatic Applications of Artificial Intelligence
Seung Soo Lee (Univ. of Ulsan)
- 09:35-10:00
-
Artificial Intelligence for Clinical Prediction
Beom Kyung Kim (Yonsei Univ.)
- 10:00-10:30
-
Imaging Reconstruction for AI Models
Jong Chul Ye (KAIST)
13:10-14:30
KASL Symposium 4
Integrative Approaches to Alcohol-Related Hepatic Disorders
Chair: Dominique Thabut (Sorbonne Univ., France), Sang Gyune Kim (Soonchunhyang Univ.)
- 13:10-13:30
-
Sex and Gender Differences in Alcohol-Associated Liver Disease
Young Chang (Soonchunhyang Univ.)
- 13:30-13:50
-
Altered Mental Status in Alcoholic Cirrhosis: Etiologies Other Than Hepatic Encephalopathy
Barjesh Chander Sharma (Govind Ballabh Pant Hospital, India)
- 13:50-14:10
-
Emerging Regimens Competing with Glucocorticoids for Severe Alcoholic Hepatitis
Sumeet Asrani (Baylor Univ., USA)
- 14:10-14:30
-
Multidisciplinary Approaches to Treat Alcohol-Associated Liver Disease
Seong Hee Kang (Korea Univ.)
07:30-08:50
KASL Special Interest Group 6. The Korean Alcohol-Related Problem Study Group
KASL-BATL Joint Session: Alcohol and Environmental Cues in Liver Disease
Chair: Wonhyo Seo (Ewha Womans Univ.), Yoon Mee Yang (Kangwon National Univ.)
- 07:30-07:50
-
Hepatic Glutamate Signaling Pathway in Alcohol-Associated Liver Disease
Won-Il Jeong (KAIST)
- 07:50-08:10
-
IRONing Out MASLD: Hepatocyte Messages to Adipose Tissue
Chang Yeob Han (Jeonbuk National Univ.)
- 08:10-08:30
-
Calibration of Gut-Liver Axis via Bile Acid and Neutrophils
Yong-Hyun Han (Kangwon National Univ.)
- 08:30-08:50
-
Diagnosis and Treatment of Liver Disease Using Extracellular Vesicles
Shuji Terai (Niigata Univ., Japan)
